We have developed C-STEMTM : a proprietary technology for the mass-production of cell therapies.
A series of proprietary cell therapy programs for co-development or licensing
ガリアン賞のメディカルスタートアップアワード（Prix Galien MedStartup）の授賞式が2020年10月26日、米国ボストンで開催され、細胞治療を専門とするフランスのバイオテクノロジー企業TreeFrog Therapeuticsが主導するQC-Stemコンソーシアムが、受賞の栄誉に輝きました。QC-Stemには、アメリカ、フランス、日本の各国から、iPS細胞の品質に関する世界最高レベルの科学者たちが参加しています。今後数ヶ月間にわたり、iPS細胞の大量生産のためにTreeFrog Therapeuticsが開発した新技術をQC-Stemの専門家たちが評価します。...
29 January, 2021 News Press Video
We are building an Application Scientists team that will be working at the interface of R&D, Process Dev and Business Development teams to keep expanding our pipeline and ensure good execution of external projects. ...
24 December, 2020 Jobs News
Within the Research Team, you will be leading or contributing to several types of research projects towards Therapeutical Products development, starting with a strong focus on neurologic fields....
24 December, 2020 Jobs NewsI am test text for Image with text shortcode. |
TreeFrog Therapeutics is a stem cell company based in Bordeaux, France, which aims at supporting the advent and industrial development of stem cell therapies. TreeFrog Therapeutics has developed C-Stem, a technology platform to scale-up cell therapy manufacturing. Based on high throughput stem cell encapsulation, C-Stem enables the mass production of human induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs) in bioreactors, as well as their differentiation into the desired cell type. Founded by Kevin Alessandri and Maxime Feyeux, TreeFrog Therapeutics is a startup company which aims at providing access to cell therapies for all.